￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Patients with TRK fusion-positive sarcoma may choose to discontinue larotrectinib

2026-02-01 22:25:32

Check Details
Selinisol inhibits XPO1 with potential for R/R AML in pediatric patients

2026-02-01 22:25:32

Check Details
Why Vigabatrin/vigabatrin is not recommended for patients over 10 years old

2026-02-01 22:25:32

Check Details
Is pimetibi currently on the market in the country?

2026-02-01 22:25:32

Check Details
What issues should you pay special attention to when using Platinib?

2026-02-01 22:25:32

Check Details
Capmatinib belongs to the first generation of targeted drugs

2026-02-01 22:25:32

Check Details
The necessity and process of genetic testing before larotinib/larlotinib treatment

2026-02-01 22:25:32

Check Details
What are the possible side effects of stopping selinesol suddenly?

2026-02-01 22:25:32

Check Details
Precautions when using Vigabatrin/vigabatrin in combination with other anti-epileptic drugs

2026-02-01 22:25:32

Check Details
What is the real clinical therapeutic effect of Pimetibi?

2026-02-01 22:25:32

Check Details
How effective is platinib in treating RET fusion-positive lung cancer?

2026-02-01 22:25:32

Check Details
How to adjust the dosage of capmatinib

2026-02-01 22:25:32

Check Details
Category
相关知识